ASCEND BY NTHRYS
Research Abroad Products

Transcriptomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 145–156 of 200 project topics
Fusion Gene and Cancer-Specific Transcript Detection Service
A specialized commercial service platform detecting oncogenic fusion transcripts and aberrant splicing patterns through long-read sequencing with clinical-grade reporting. This addresses the oncology diagnostic market with high-margin per-test revenue and recurring referrals from hospitals and cancer centers.
Long-Read Transcriptomics Service Platforms Click to view more details →
RNA Modification Quantification Technology and Software Suite
A proprietary software-hardware package integrating long-read sequencing with direct RNA modification detection algorithms to profile m6A, pseudouridine, and other epitranscriptomic marks. This novel capability creates a new revenue stream from epigenetics researchers and biotech companies developing epitranscriptomic-targeting therapeutics.
Long-Read Transcriptomics Service Platforms Click to view more details →
Viral RNA Pathogen Characterization and Typing Platform
A commercial diagnostic platform using long-read sequencing to fully characterize viral genomes, detect variants, and identify recombination events in single runs. This serves public health agencies and clinical labs with rapid turnaround and comprehensive variant reporting, creating high-volume recurring testing revenue.
Long-Read Transcriptomics Service Platforms Click to view more details →
Transcript Structure Assembly and Quantification Enterprise Software
Enterprise-grade bioinformatics software automating transcript reconstruction, quality filtering, and abundance quantification from long-read sequencing data with minimal manual curation. This platform captures value through per-institution licensing and premium support, enabling genomics labs to maximize their sequencing instrument investment.
Long-Read Transcriptomics Service Platforms Click to view more details →
Polycistronic mRNA and Non-Coding RNA Discovery Service
A specialized discovery service identifying polycistronic transcripts, long non-coding RNAs, and circular RNAs through comprehensive long-read transcriptomics with expert annotation. This serves synthetic biology and RNA therapeutics companies seeking novel therapeutic targets, with premium project-based fees and milestone-driven contracts.
Long-Read Transcriptomics Service Platforms Click to view more details →
Standardized Long-Read Transcriptome Reference Database Platform
A commercialized cloud platform housing curated, standardized long-read transcriptome reference datasets from multiple tissues and disease states with secure API access. This creates predictable subscription revenue from pharmaceutical companies using the database for target validation, with additional licensing fees for custom private datasets.
Long-Read Transcriptomics Service Platforms Click to view more details →
Real-time Immune Cell Atlas SaaS Platform
A cloud-based platform that maps and visualizes immune cell transcriptional signatures in real-time during immunotherapy treatment cycles. Enables oncology centers and biotech firms to monitor patient response trajectories and optimize therapeutic protocols through continuous transcriptomic surveillance.
Immune Transcriptomics Immunotherapy Platforms Click to view more details →
CAR-T Efficacy Prediction Engine with RNA Profiling
Commercial software that predicts CAR-T cell therapy success by analyzing T-cell exhaustion transcriptomes before infusion. Helps cell therapy manufacturers and hospitals reduce treatment failures, improve patient selection, and increase reimbursement rates by 35-40%.
Immune Transcriptomics Immunotherapy Platforms Click to view more details →
Checkpoint Inhibitor Response Biomarker Discovery Service
A managed service platform that identifies predictive transcriptomic signatures for PD-1/PD-L1 and CTLA-4 inhibitor response in patient cohorts. Generates validated biomarkers for pharma clients that enable precision dosing strategies and companion diagnostic partnerships worth millions in licensing revenue.
Immune Transcriptomics Immunotherapy Platforms Click to view more details →
Tumor Microenvironment Immune Profiling Workflow Tool
An integrated bioinformatics platform that sequences and analyzes immune transcriptomes from tumor-infiltrating lymphocytes in solid tumors. Delivers actionable immune microenvironment reports to clinical oncology centers, generating recurring SaaS revenue and supporting combination therapy development decisions.
Immune Transcriptomics Immunotherapy Platforms Click to view more details →
Multi-omics Immunotherapy Response Analytics Dashboard
A white-label analytics dashboard integrating RNA-seq, TCR sequencing, and clinical outcomes to track immunotherapy response mechanisms. Licenses to hospital networks and CROs as a subscription service that improves clinical trial enrollment efficiency and accelerates time-to-market for immunotherapies.
Immune Transcriptomics Immunotherapy Platforms Click to view more details →
Adaptive Immune Repertoire Monitoring Commercial Kit
A proprietary transcriptomics kit and cloud analysis service that tracks clonal T-cell and B-cell expansion during immunotherapy. Generates recurring revenue through kit sales and data analysis subscriptions while enabling real-time patient stratification for dose optimization and safety monitoring.
Immune Transcriptomics Immunotherapy Platforms Click to view more details →